Key facts
- This page summarizes William Kane's Form 4 filing for Citius Pharmaceuticals, Inc. (CTXR).
- 1 reported transaction and 11 derivative rows are listed below.
- Accepted by SEC: 06 Oct 2022, 16:10.
William Kane - 04 Oct 2022 Form 4 Insider Report for Citius Pharmaceuticals, Inc. (CTXR)
- Reporting relationship
- Director
- Issuer ticker
- CTXR
- Reported as of
- 04 Oct 2022
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 06 Oct 2022, 16:10:20 UTC
- Prior SEC filing
- 13 Oct 2021
- Source filing
- View source filing
- Reporting owner signature
- /s/ Alexander M. Donaldson, by power of attorney
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
William Kane filed Form 4 for Citius Pharmaceuticals, Inc. (CTXR) on 06 Oct 2022.
Change
- Previous filing in this sequence was filed on 13 Oct 2021.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
CTXR
transaction
Derivative
Options to Purchase Common Stock
Award
- Transaction value
- $0
- Shares
- +75,000
- Change %
- Price
- $0.000000
- Shares after
- 75,000
- Date
- 04 Oct 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 75,000
- Exercise price
- $1.25
- Footnotes
- F1
CTXR
holding
Derivative
Options to Purchase Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 75,000
- Date
- 04 Oct 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 75,000
- Exercise price
- $2.04
- Footnotes
- F2
CTXR
holding
Derivative
Options to Purchase Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 15,000
- Date
- 04 Oct 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 15,000
- Exercise price
- $2.00
- Footnotes
- F3
CTXR
holding
Derivative
Options to Purchase Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 25,000
- Date
- 04 Oct 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 25,000
- Exercise price
- $1.69
- Footnotes
- F4
CTXR
holding
Derivative
Options to Purchase Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 35,000
- Date
- 04 Oct 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 35,000
- Exercise price
- $1.01
- Footnotes
- F5
CTXR
holding
Derivative
Options to Purchase Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 25,000
- Date
- 04 Oct 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 25,000
- Exercise price
- $1.39
- Footnotes
- F6
CTXR
holding
Derivative
Options to Purchase Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 25,000
- Date
- 04 Oct 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 25,000
- Exercise price
- $0.6700
- Footnotes
- F7
CTXR
holding
Derivative
Options to Purchase Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 15,000
- Date
- 04 Oct 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 15,000
- Exercise price
- $1.62
- Footnotes
- F8
CTXR
holding
Derivative
Options to Purchase Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 10,000
- Date
- 04 Oct 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 10,000
- Exercise price
- $3.45
- Footnotes
- F9
CTXR
holding
Derivative
Options to Purchase Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 12,071
- Date
- 04 Oct 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 12,071
- Exercise price
- $0.0150
- Footnotes
- F10
CTXR
holding
Derivative
Options to Purchase Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 13,334
- Date
- 04 Oct 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 13,334
- Exercise price
- $12.00
- Footnotes
- F11
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 11 footnotes
Footnote F1
The options were granted on October 4, 2022. The options will vest 100% on the one-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of the vesting date.
Footnote F2
The options were granted on October 11, 2021. The options will vest 100% on the one-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of the vesting date.
Footnote F3
The options vested in full on July 22, 2022.
Footnote F4
The options vested in full on February 16, 2022.
Footnote F5
The options vested in full on October 6, 2021.
Footnote F6
The options vested in full on July 7, 2021.
Footnote F7
The options vested in full on October 8, 2020.
Footnote F8
The options vested in full on September 4, 2019.
Footnote F9
The options vested in full on September 13, 2018.
Footnote F10
The options vested in 1/3 increments over a three-year period with the first installment vesting on March 28, 2015.
Footnote F11
The options vested in full on the first anniversary of the date of grant.